These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 16761122)

  • 21. Exploring molecular links between lymph node invasion and cancer prognosis in human breast cancer.
    Kim S; Nam H; Lee D
    BMC Syst Biol; 2011; 5 Suppl 2(Suppl 2):S4. PubMed ID: 22784575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years' follow-up.
    Falck AK; Bendahl PO; Chebil G; Olsson H; Fernö M; Rydén L
    Breast Cancer Res Treat; 2013 Jul; 140(1):93-104. PubMed ID: 23807420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular detection of breast cancer metastasis in sentinel lymph nodes by reverse transcriptase polymerase chain reaction (RT-PCR): identifying, evaluating and establishing multi-marker panels.
    Wallwiener CW; Wallwiener M; Kurth RR; Röhm C; Neubauer H; Banys MJ; Staebler A; Schönfisch B; Meuer SC; Giese T; Fehm TN
    Breast Cancer Res Treat; 2011 Dec; 130(3):833-44. PubMed ID: 21858660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A validation study of a new molecular diagnostic assay: the Dartmouth-Hitchcock Medical Center experience with the GeneSearch BLN assay in breast sentinel lymph nodes.
    Tafe LJ; Schwab MC; Lefferts JA; Wells WA; Tsongalis GJ
    Exp Mol Pathol; 2010 Feb; 88(1):1-6. PubMed ID: 19840784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of public cancer datasets and signatures identifies TP53 mutant signatures with robust prognostic and predictive value.
    Lehmann BD; Ding Y; Viox DJ; Jiang M; Zheng Y; Liao W; Chen X; Xiang W; Yi Y
    BMC Cancer; 2015 Mar; 15():179. PubMed ID: 25886164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
    Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. WWOX--the FRA16D cancer gene: expression correlation with breast cancer progression and prognosis.
    Płuciennik E; Kusińska R; Potemski P; Kubiak R; Kordek R; Bednarek AK
    Eur J Surg Oncol; 2006 Mar; 32(2):153-7. PubMed ID: 16360296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene expression in early stage cervical cancer.
    Biewenga P; Buist MR; Moerland PD; Ver Loren van Themaat E; van Kampen AH; ten Kate FJ; Baas F
    Gynecol Oncol; 2008 Mar; 108(3):520-6. PubMed ID: 18191186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer.
    Nakamura Y; Yasuoka H; Tsujimoto M; Yang Q; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
    Clin Cancer Res; 2003 Nov; 9(14):5313-7. PubMed ID: 14614015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene expression patterns as marker for 5-year postoperative prognosis of primary breast cancers.
    Onda M; Emi M; Nagai H; Nagahata T; Tsumagari K; Fujimoto T; Akiyama F; Sakamoto G; Makita M; Kasumi F; Miki Y; Tanaka T; Tsunoda T; Nakamura Y
    J Cancer Res Clin Oncol; 2004 Sep; 130(9):537-45. PubMed ID: 15235906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study of the correlation between HER-2 gene and lymphangiogenesis and their prognostic significance in human breast cancer].
    Zhang GH; Yang WT; Zhou XY; Zeng Y; Lu HF; Shi DR
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):155-60. PubMed ID: 17425844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of new genes associated with breast cancer progression by gene expression analysis of predefined sets of neoplastic tissues.
    Cimino D; Fuso L; Sfiligoi C; Biglia N; Ponzone R; Maggiorotto F; Russo G; Cicatiello L; Weisz A; Taverna D; Sismondi P; De Bortoli M
    Int J Cancer; 2008 Sep; 123(6):1327-38. PubMed ID: 18561318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of axillary lymph node status of breast cancer patients by tumorbiological factors of the primary tumor.
    Fehm T; Maul H; Gebauer S; Scharf A; Baier P; Sohn C; Jäger W; Gebauer G
    Strahlenther Onkol; 2005 Sep; 181(9):580-6. PubMed ID: 16170485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Which cyclin E prevails as prognostic marker for breast cancer? Results from a retrospective study involving 635 lymph node-negative breast cancer patients.
    Sieuwerts AM; Look MP; Meijer-van Gelder ME; Timmermans M; Trapman AM; Garcia RR; Arnold M; Goedheer AJ; de Weerd V; Portengen H; Klijn JG; Foekens JA
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3319-28. PubMed ID: 16740753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor gene expression and prognosis in breast cancer patients with 10 or more positive lymph nodes.
    Cobleigh MA; Tabesh B; Bitterman P; Baker J; Cronin M; Liu ML; Borchik R; Mosquera JM; Walker MG; Shak S
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8623-31. PubMed ID: 16361546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical application of the one-step nucleic acid amplification method to detect sentinel lymph node metastasis in breast cancer.
    Sagara Y; Ohi Y; Matsukata A; Yotsumoto D; Baba S; Tamada S; Sagara Y; Matsuyama Y; Ando M; Rai Y; Sagara Y
    Breast Cancer; 2013 Apr; 20(2):181-6. PubMed ID: 22203582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reasoning with uncertainty in pathology: artificial neural networks and logistic regression as tools for prediction of lymph node status in breast cancer patients.
    Marchevsky AM; Shah S; Patel S
    Mod Pathol; 1999 May; 12(5):505-13. PubMed ID: 10349989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer.
    Nakamura Y; Yasuoka H; Tsujimoto M; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
    Breast Cancer Res Treat; 2005 May; 91(2):125-32. PubMed ID: 15868440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Introducing a novel and robust technique for determining lymph node status in colorectal cancer.
    Hogan J; Judge C; O'Callaghan M; Aziz A; O'Connor C; Burke J; Dunne C; Walsh S; Kalady M; Coffey JC
    Ann Surg; 2014 Jul; 260(1):94-102. PubMed ID: 24169164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.